2003
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
Abstract: Children fulfilling the diagnostic criteria for Kawasaki disease should be treated with IVIG (2 gm/kg single dose) within 10 days of onset of symptoms.
Search citation statements
Paper Sections
Select...
231
32
22
2
Citation Types
2
147
0
13
Year Published
Range
2000
2026
Publication Types
Select...
212
48
19
3
Relationship
1
281
Authors
Journals
Cited by 282 publications
(162 citation statements)
References 53 publications
2
147
0
13
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Among our patient cohort, the CAL complication rate ≤ 30 days of illness in the dKD group was not significantly different from that of the tKD group who had received initial IVIG therapy (9.9 % vs. 7.6 %). In addition, these rates were comparable to those seen in the recent, nationwide surveys in Japan (10.0 % in 2007–2008 and 8.5 % in 2009–2010) [ 11 , 12 ], and lower than those seen in 20–40 % of the historical cohort that received aspirin alone [ 13 , 14 ]. These findings partially support the recommendations of the Japanese rather than American guidelines for KD management; the former state that IVIG therapy is not definitely indicated for spontaneously defervesced KD because of the lesser severity of the disease [ 1 , 2 ].…”
Section: Discussion
supporting
confidence: 80%